Disease | c syndrome |
Comorbidity | |cardiovascular disease |
Sentences | 66 |
PubMedID- 25633268 | Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd). |
PubMedID- 23323622 | Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. |
PubMedID- 20689417 | Recent findings: individuals infected with hiv frequently demonstrate a metabolic syndrome associated with atherosclerosis and cardiovascular disease. |
PubMedID- 21122628 | Background: metabolic syndrome is associated with increased cardiovascular disease (cvd) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (ldl-c). |
PubMedID- 23524050 | The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease. |
PubMedID- 24676221 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
PubMedID- 19958158 | Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress. |
PubMedID- 21845221 | Nafld is becoming a risk factor for diabetes and cardiovascular diseases (cvds) independently of insulin resistance, metabolic syndrome, plasma lipid levels, and other usual risk factors [3, 4]. |
PubMedID- 24396692 | Furthermore, nafld is emerging as a risk factor for diabetes and cardiovascular disease, independently of insulin resistance, metabolic syndrome, plasma lipid level, and other traditional risk factors [2]. |
PubMedID- 22359422 | The metabolic syndrome among patients with cardiovascular disease in accra, ghana. |
PubMedID- 22760893 | Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases. |
PubMedID- 23199128 | In this review, we first describe the population trend in the degree of obesity as measured by the body mass index (bmi), and review prospective cohort studies that reported associations of obesity measures and metabolic syndrome (mets) with cardiovascular diseases (cvd) in japanese. |
PubMedID- 22417140 | Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease. |
PubMedID- 22424625 | Objective: the association of metabolic syndrome (mets) with cardiovascular diseases (cvd) has not been adequately explored in middle-aged and elderly chinese. |
PubMedID- 24716162 | It is also strongly related to other pathological conditions, including obesity, diabetes, cardiovascular diseases, and symptoms of metabolic syndrome. |
PubMedID- 20671994 | On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome. |
Page: 1 2